Allogeneic Hematopoietic Cell Transplantation in Patients with a Hematologic Malignancy and a Prior History of Breast Cancer

Transplant outcomes were compared to 289 control patients without a history of breast cancer from the same time period. Main outcomes included survival, disease-free survival, non-relapse mortality, relapse or progression of hematologic malignancy, and incidence of recurrent breast cancer after hematopoietic cell transplantation.